Professional Documents
Culture Documents
PII: S1262-3636(19)30063-1
DOI: https://doi.org/10.1016/j.diabet.2019.04.003
Reference: DIABET 1087
Please cite this article as: Mooventhan A, Chaudari SS, Venugopal V, Effect of cold hip
baths on blood glucose levels in patients with type 2 diabetes mellitus: a pilot study,
Diabetes and Metabolism (2018), https://doi.org/10.1016/j.diabet.2019.04.003
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1
Effect of cold hip baths on blood glucose levels in patients with type 2 diabetes mellitus: a
pilot study
PT
1
MD (Naturopathy), Assistant Medical Officer/Lecturer-II, Department of Naturopathy, Govt.
RI
Yoga and Naturopathy Medical College and Hospital, Arumbakkam, Chennai, Tamil Nadu,
India
SC
2
Intern, Division of Yoga and Life Sciences, The School of Yoga and Naturopathic Medicine, S-
VYASA University, Bengaluru, Karnataka, India
U
3
Assitant Medical Officer/Lecturer-II, Department of Yoga, Govt. Yoga and Naturopathy
N
Medical College and Hospital, Arumbakkam, Chennai, Tamil Nadu, India
A
*Corresponding author:
M
A. Mooventhan, MD (Naturopathy)
Assistant Medical Officer/Lecturer-II, Department of Naturopathy, Govt. Yoga and Naturopathy
D
Medical College and Hospital, Arumbakkam, Chennai 600106, Tamil Nadu, India
TE
Email: dr.mooventhan@gmail.com
Mobile tel: +91 98 4445 7496
EP
conventional medicine is the first line of management, complementary therapies are being
increasingly used in the management of T2DM [1]. Cold hip baths (CHBs) are commonly
employed by naturopathic hospitals in India to treat T2DM. However, there is a lack of scientific
PT
reports on their effect on blood glucose levels (BGLs) [2]. For this reason, the present pilot study
was conducted to evaluate the effect of CHBs on BGLs in patients with T2DM.
RI
Eight T2DM patients (five men, three women) aged 51.25 ± 5.44 years were recruited for the
SC
study. Men and women with a history of T2DM on stable medication over the past month who
were willing to participate were included. Participants with a history of type 1 diabetes, T2DM
U
complications, psychiatric problems and aversion to cold water were excluded.
N
A
The study protocol was approved by the relevant institutional ethics committee, and informed
M
A single-group repeated-measures design was used for this pilot study. All subjects underwent
D
one CHB session and one control session (CS), both on the same day. All CHBs were taken
TE
using a specially designed tub called a ‘hip bathtub’ made of fibre. Participants were advised to
EP
sit in a tub of water (15o–16o C) filled to a level that allowed immersion of the area between the
umbilicus and mid-thigh. They were also advised to rest their feet on a footrest (outside the tub),
CC
while resting their hands (not touching the water) on the sides of the tub [2]. During the CS,
participants were asked to sit comfortably in a chair with no hydrotherapy intervention. The
A
Random BGLs were measured using a continuous glucose-monitoring sensor (FreeStyle Libre
Pro Flash Glucose Monitoring System; Abbott Diabetes Care, Witney, UK) at baseline (just
before), during and after (immediately, at 15 min and at 30 min) each interventional session.
Statistical analyses of data collected within and between sessions were performed using repeated
PT
measures of analysis of variance (ANOVA) and post-hoc analyses with Bonferroni adjustment
for multiple comparisons, using SPSS version 16.0 software (SPSS Inc., Chicago, IL, USA).
RI
There were no significant differences in BGLs at baseline in the between-session analysis.
SC
However, there was a significant reduction in BGLs after 30 min with CHBs compared with
CSs. Likewise, the within-session analysis showed a trend towards a gradual reduction of BGL
U
with the CHB, but not the CS. None of the participants reported any adverse events either during
These results suggest that a 20-min CHB is effective for reducing BGL in patients with T2DM
compared with a simple rest. Thus, CHBs could be considered a complementary treatment
D
modality when treating patients with T2DM. Also, the trend towards a gradual reduction in
TE
BGLs with CHBs suggests that the glucose-lowering effect begins during the intervention itself,
then gradually accelerates over a period of time (particularly after the intervention) to produce a
EP
The following possible mechanisms may explain the BGL reduction with CHB sessions. (i)
thermoregulation [2,3]. According to a previous study, immersion in cold water (20° C) nearly
doubles the metabolic rate and, at 14° C, more than quadruples it. Thus, the CHB could have
4
gradually increased metabolic rates by utilization of blood glucose [2]. (ii) The transient receptor
potential melastatin 8 (TRPM8) ion channel plays a crucial role in detecting cool-to-cold
temperatures in vivo. TRPM8 activation is associated with ‘browning’ of white adipose tissue
and acceleration of energy utilization [4]. Cold exposure is associated with an increase in
PT
metabolic heat production (shivering and non-shivering thermogenesis) to prevent a fall in core
body temperature. Shivering is a major source of heat production. However, during mild cold
RI
exposures, non-shivering thermogenesis, primarily mediated by metabolically active brown
SC
adipose tissue [5], has a vital role in producing a physiological response. Thus, CHBs are also
U
through activation of the TRPM8 ion channel. (iii) CHBs are reported to prompt parasympathetic
N
activation [2] which, in turn, is known to promote insulin secretion [6], and (iv) there is also
A
evidence to suggest that exposure to cold (14–15o C) induces a 43% increase in insulin
M
Ours is the first study to report on the effects of CHBs on BGLs in patients with T2DM. All
TE
assessments were done using standard equipment. In addition, although the interventions took
place at different times during the same day (CHBs were between 0900–1000 h in the morning;
EP
CSs were between 1700–1800 h in the evening), the mean difference in BGL at baseline between
the CHB and CS was 0.62 mg/dL, with no significant difference at baseline according to
CC
As this experiment was conducted as a pilot study, our sample size could not be calculated based
on any previous study. Therefore, although the results of this preliminary study are encouraging,
the difficulty in generalizing these data in the absence of an adequate sample size limits the
applicability of our findings. Thus, a randomized controlled trial involving a larger sample size is
5
now required to substantiate these results. However, based on our present data, it may be
concluded that a 20-min CHB could be effective in lowering BGLs in patients with T2DM.
PT
SOURCE OF FUNDING: None
RI
CONFLICT OF INTEREST: None declared
SC
U
N
A
M
D
TE
EP
CC
A
6
REFERENCES
Abdominal Pack on Blood Glucose Level and Cardiovascular Functions in Patients with
PT
doi: 10.7860/JCDR/2018/29561.11328.
2. Shrestha RL, Sujatha KJ. Effect of cold hip bath on autonomic variables in healthy
RI
individuals: A randomized control trial. J Res Educ Indian Med 2017;23:1-4.
SC
doi.10.5455/JREIM.82-1502188415.
3. Brychta RJ, Chen KY. Cold-induced thermogenesis in humans. Eur J Clin Nutr
U
2017;71:345-52. doi: 10.1038/ejcn.2016.223. Epub 2016 Nov 23.
N
4. Kenny GP, Sigal RJ, McGinn R. Body temperature regulation in diabetes. Temperature
A
(Austin) 2016;3:119-45. doi: 10.1080/23328940.2015.1131506.
M
doi: 10.1080/23328940.2015.1040604.
6. D'Alessio DA, Kieffer TJ, Taborsky GJ Jr, Havel PJ. Activation of the parasympathetic
EP
7. Hanssen MJ, Hoeks J, Brans B, van der Lans AA, Schaart G, van den Driessche JJ, et al.
A
Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes
RI
SC
Table
U
N
Table I
A
Study results at baseline, during and after cold hip bath (CHB) and control sessions
M
Parameters CHB session (n = 8) Control session (n = 8) P (between sessions)
Baseline 165.88 ± 59.48 166.50 ± 58.53 1.000
ED
During 160.00 ± 57.29 165.13 ± 54.70 1.000
Blood glucose Post-1 (immediately 145.13 ± 48.62 167.13 ± 51.75 0.203
levels (mg/dL) after)
PT
P = 0.004 P = 0.791
* P < 0.05 for within-session analyses (vs respective baseline); ** P < 0.05 for between-session analyses (by repeated measures of analysis
A
of variance and post-hoc analysis with Bonferroni adjustment for multiple comparisons)